Product Details
Place of Origin: China
Brand Name: Sunshine
Certification: ISO,COA
Model Number: 70374-39-9
Payment & Shipping Terms
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: Bag,Drum
Delivery Time: 7-15 days
Payment Terms: L/C, D/A, T/T, Western Union
Supply Ability: TON
CAS NO:: |
70374-39-9 |
Appearance:: |
Crystalline Solid |
Molecular Formula:: |
C13H10ClN3O4S2 |
Molecular Weight:: |
371.81900 |
EINECS NO:: |
630-354-7 |
MDL NO:: |
MFCD00866163 |
CAS NO:: |
70374-39-9 |
Appearance:: |
Crystalline Solid |
Molecular Formula:: |
C13H10ClN3O4S2 |
Molecular Weight:: |
371.81900 |
EINECS NO:: |
630-354-7 |
MDL NO:: |
MFCD00866163 |
Product Description:
Product Name: Lornoxicam CAS NO: 70374-39-9
Synonyms:
6-chloro-4-hydroxy-2-methyl-1,1-dioxo-N-pyridin-2-ylthieno[2,3-e]thiazine-3-carboxamide;
Chemical & Physical Properties:
Appearance: Crystalline Solid
Assay :≥99.00%
Density: 1.727g/cm3
Melting Point: 225-230℃ (dec.)
Refractive Index: 1.741
Storage Condition: -20℃ Freezer
Safety Information:
Safety Statements: S26; S36
HS Code: 2934999090
Risk Statements: R36/37/38
Hazard Code: Xi
Cyclooxygenase inhibitor; structurally similar to Tenoxicam. Anti-inflammatory; analgesic. Lornoxicam (Trade name: “Xefo”) belongs to a non-steroidal anti-inflammatory drug. As a kind of oxicam class drug, it has analgesic, anti-inflammatory and antipyretic properties. It can be used for the treatment of various type of acute mild to moderate pain which results from inflammatory diseases of the joints, osteoarthritis, surgery, sciatica and rheumatic diseases. Lornoxicam is capable of potently inhibiting the prostaglandin biosynthesis process, making it have highly pronounced efficacy. The exact mechanism of Lornoxicam is not exactly understood. However, it is indicated that Lornoxicam can inhibit the prostaglandin and thromboxane synthesis by inhibiting both COX-1 and COX-2, leading to reduction of inflammation, pain, fever, and swelling. For the treatment of acute mild to moderate pain, as well as pain and inflammation of the joints caused by certain types of rheumatic diseases.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.